Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,651,776
  • Shares Outstanding, K 176,315
  • Annual Sales, $ 15,405 M
  • Annual Income, $ 1,373 M
  • EBIT $ 3,316 M
  • EBITDA $ 4,451 M
  • 60-Month Beta 1.50
  • Price/Sales 2.08
  • Price/Cash Flow 10.93
  • Price/Book 5.43

Options Overview Details

View History
  • Implied Volatility 35.60% ( +1.59%)
  • Historical Volatility 26.70%
  • IV Percentile 92%
  • IV Rank 77.20%
  • IV High 40.05% on 10/22/24
  • IV Low 20.55% on 03/20/24
  • Put/Call Vol Ratio 0.54
  • Today's Volume 80
  • Volume Avg (30-Day) 849
  • Put/Call OI Ratio 1.49
  • Today's Open Interest 13,219
  • Open Int (30-Day) 11,850

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.37
  • Number of Estimates 7
  • High Estimate 2.40
  • Low Estimate 2.27
  • Prior Year 2.30
  • Growth Rate Est. (year over year) +3.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
179.28 +3.30%
on 03/04/25
198.90 -6.89%
on 02/20/25
-8.25 (-4.26%)
since 02/14/25
3-Month
179.28 +3.30%
on 03/04/25
220.00 -15.82%
on 02/06/25
-13.87 (-6.97%)
since 12/13/24
52-Week
179.28 +3.30%
on 03/04/25
256.34 -27.76%
on 03/19/24
-69.07 (-27.17%)
since 03/14/24

Most Recent Stories

More News
Is IQVIA Holdings Stock Underperforming the Dow?

IQVIA Holdings has significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s prospects.

A : 121.18 (+3.28%)
$DOWI : 41,488.19 (+1.65%)
IQV : 185.19 (+2.07%)
IQV : 185.19 (+2.07%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 9.66 (+0.84%)
MEDP : 324.95 (+2.21%)
RGEN : 150.62 (+5.74%)
AZTA : 36.80 (+0.66%)
IQV : 185.19 (+2.07%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 9.66 (+0.84%)
MEDP : 324.95 (+2.21%)
AZTA : 36.80 (+0.66%)
CRL : 171.04 (+2.46%)
IQV : 185.19 (+2.07%)
Rep. Marjorie Taylor Greene Is Betting Big on Nvidia Stock. Should You?

The politician last disclosed a purchase worth up to $15,000 in NVDA in January.

NVDA : 121.67 (+5.27%)
GOOGL : 165.49 (+1.68%)
AAPL : 213.49 (+1.82%)
TSLA : 249.98 (+3.86%)
ILMN : 85.60 (+1.84%)
MET : 80.41 (+3.49%)
AMZN : 197.95 (+2.09%)
IQV : 185.19 (+2.07%)
IQVIA Holdings Stock: Analyst Estimates & Ratings

IQVIA Holdings has trailed the broader market over the past year, but analysts on Wall Street maintain a very bright outlook on the stock’s growth prospects.

XLV : 144.93 (+0.76%)
$SPX : 5,638.94 (+2.13%)
JPM : 232.44 (+3.22%)
IQV : 185.19 (+2.07%)
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight

Graphic processing units (GPUs) and artificial intelligence (AI) are among the most searched terms online these days, making companies like NVIDIA NVDA the focal point of investors’ interest. While NVIDIA’s...

NVDA : 121.67 (+5.27%)
ILMN : 85.60 (+1.84%)
DXCM : 70.69 (+3.23%)
IQV : 185.19 (+2.07%)
Waste Connections Q4 Earnings Miss Estimates, Revenues Rise Y/Y

Waste Connections. Inc. WCN reported mixed fourth-quarter 2024 results, wherein earnings missed the Zacks Consensus Estimates, while revenues beat the same.See Zacks Earnings Calendar to stay ahead of...

WCN : 185.29 (+1.13%)
RSG : 232.01 (+1.19%)
IQV : 185.19 (+2.07%)
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

AZTA : 36.80 (+0.66%)
CRL : 171.04 (+2.46%)
IQV : 185.19 (+2.07%)
Nvidia Could Power Up This Under-the-Radar Healthcare Stock

A partnership with Nvidia is bound to yield fruitful results for this little-known company.

SERV : 7.66 (+9.12%)
NVDA : 121.67 (+5.27%)
SOUN : 10.34 (+16.05%)
$SPX : 5,638.94 (+2.13%)
IQV : 185.19 (+2.07%)
West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For

West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For

AZTA : 36.80 (+0.66%)
WST : 230.11 (+2.85%)
IQV : 185.19 (+2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in...

See More

Key Turning Points

3rd Resistance Point 189.97
2nd Resistance Point 187.75
1st Resistance Point 186.47
Last Price 185.19
1st Support Level 182.97
2nd Support Level 180.75
3rd Support Level 179.47

See More

52-Week High 256.34
Fibonacci 61.8% 226.90
Fibonacci 50% 217.81
Fibonacci 38.2% 208.72
Last Price 185.19
52-Week Low 179.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar